Overview Dividends

(CROX) Crocs - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2270461096

Clogs, Sandals, Sneakers, Slides, Boots

Footwear
Market Cap in USD: 4,749m

IPO / Inception: 2006-02-08
Return 12m vs S&P 500: -35.3%

EPS (Earnings per Share)

EPS CAGR: -42.31%
EPS Trend: -25.6%

Last SUE: -4.00
Qual. Beats: 0

Revenue

Rev. CAGR: 15.17%
Rev. Trend: 64.4%

Last SUE: 1.95
Qual. Beats: 1

Dividends

Currently no dividends paid

Risk via 5d forecast
Volatility	46.7%
Value at Risk 5%th	64.0%
Relative Tail Risk	-16.76%

Reward TTM
Sharpe Ratio	-0.18
Alpha	-43.93
CAGR/Max DD	-0.22

Character TTM
Hurst Exponent	0.566
Beta	1.140
Beta Downside	0.453

Drawdowns 3y
Max DD	54.04%
Mean DD	28.15%
Median DD	31.26%

Description: CROX Crocs January 09, 2026

Crocs, Inc. (NASDAQ:CROX) designs, manufactures, and markets a broad portfolio of casual footwear and accessories-including clogs, sandals, sneakers, and related items-under the Crocs and HEYDUDE brands. The company reaches consumers through a mix of wholesale partners, company-owned retail stores, e-commerce sites, third-party marketplaces, and kiosk or store-in-store concepts, operating globally from its headquarters in Broomfield, Colorado.

Recent financials (Q3 2024, subject to revision) show CROX generating roughly $2.5 billion in annual revenue with a gross margin around 45%, while direct-to-consumer (DTC) sales have accelerated at an estimated 20 % year-over-year rate-reflecting the broader footwear sector’s shift toward online channels. Inventory turnover has improved to approximately 3.2×, indicating better demand forecasting, and the company’s exposure to discretionary consumer spending makes it sensitive to macro-level factors such as household income trends and inflation-adjusted price elasticity.

For a deeper quantitative assessment of CROX’s valuation relative to peers, the ValueRay platform offers a concise, data-driven dashboard worth reviewing.

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (182.5m TTM) > 0 and > 6% of Revenue (6% = 244.4m TTM)

FCFTA 0.17 (>2.0%) and ΔFCFTA -3.29pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 6.86% (prev 7.31%; Δ -0.45pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.18 (>3.0%) and CFO 779.8m > Net Income 182.5m (YES >=105%, WARN >=100%)

Net Debt (1.55b) to EBITDA (378.2m) ratio: 4.10 <= 3.0 (WARN <= 3.5)

Current Ratio 1.40 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (55.2m) change vs 12m ago -7.28% (target <= -2.0% for YES)

Gross Margin 59.08% (prev 58.15%; Δ 0.94pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 90.38% (prev 86.41%; Δ 3.97pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 1.67 (EBITDA TTM 378.2m / Interest Expense TTM 180.9m) >= 6 (WARN >= 3)

Altman Z'' 4.63

(A) 0.06 = (Total Current Assets 971.2m - Total Current Liabilities 691.7m) / Total Assets 4.30b

(B) 0.79 = Retained Earnings (Balance) 3.38b / Total Assets 4.30b

(D) 1.14 = Book Value of Equity 3.33b / Total Liabilities 2.94b

Total Rating: 4.63 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 61.74

1. Piotroski 5.0pt

2. FCF Yield 11.37%

3. FCF Margin 17.59%

4. Debt/Equity 1.25

5. Debt/Ebitda 4.10

6. ROIC - WACC (= -1.11)%

7. RoE 11.08%

8. Rev. Trend 64.43%

9. EPS Trend -25.64%

What is the price of CROX shares?

As of January 11, 2026, the stock is trading at USD 86.07 with a total of 1,023,250 shares traded.
Over the past week, the price has changed by -1.01%, over one month by +0.41%, over three months by +7.07% and over the past year by -21.78%.

Is CROX a buy, sell or hold?

Crocs has received a consensus analysts rating of 4.20. Therefore, it is recommended to buy CROX.

Strong Buy: 7
Buy: 4
Hold: 4
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the CROX price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	89.8	4.3%
Analysts Target Price	89.8	4.3%
ValueRay Target Price	83	-3.5%

CROX Fundamental Data Overview January 05, 2026

P/E Trailing = 30.191
P/E Forward = 7.9051
P/S = 1.166
P/B = 3.3115
P/EG = -31.83
Beta = 1.538
Revenue TTM = 4.07b USD
EBIT TTM = 301.9m USD
EBITDA TTM = 378.2m USD
Long Term Debt = 1.32b USD (from longTermDebt, last quarter)
Short Term Debt = 84.3m USD (from shortTermDebt, last quarter)
Debt = 1.71b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.55b USD (from netDebt column, last quarter)
Enterprise Value = 6.30b USD (4.75b + Debt 1.71b - CCE 154.0m)
Interest Coverage Ratio = 1.67 (Ebit TTM 301.9m / Interest Expense TTM 180.9m)
EV/FCF = 8.80x (Enterprise Value 6.30b / FCF TTM 716.2m)
FCF Yield = 11.37% (FCF TTM 716.2m / Enterprise Value 6.30b)
FCF Margin = 17.59% (FCF TTM 716.2m / Revenue TTM 4.07b)
Net Margin = 4.48% (Net Income TTM 182.5m / Revenue TTM 4.07b)
Gross Margin = 59.08% ((Revenue TTM 4.07b - Cost of Revenue TTM 1.67b) / Revenue TTM)
Gross Margin QoQ = 58.52% (prev 61.67%)
Tobins Q-Ratio = 1.47 (Enterprise Value 6.30b / Total Assets 4.30b)
Interest Expense / Debt = 6.58% (Interest Expense 112.3m / Debt 1.71b)
Taxrate = 23.02% (43.6m / 189.4m)
NOPAT = 232.4m (EBIT 301.9m * (1 - 23.02%))
Current Ratio = 1.40 (Total Current Assets 971.2m / Total Current Liabilities 691.7m)
Debt / Equity = 1.25 (Debt 1.71b / totalStockholderEquity, last quarter 1.36b)
Debt / EBITDA = 4.10 (Net Debt 1.55b / EBITDA 378.2m)
Debt / FCF = 2.17 (Net Debt 1.55b / FCF TTM 716.2m)
Total Stockholder Equity = 1.65b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.05% (Net Income 182.5m / Total Assets 4.30b)
RoE = 11.08% (Net Income TTM 182.5m / Total Stockholder Equity 1.65b)
RoCE = 10.18% (EBIT 301.9m / Capital Employed (Equity 1.65b + L.T.Debt 1.32b))
RoIC = 7.67% (NOPAT 232.4m / Invested Capital 3.03b)
WACC = 8.78% (E(4.75b)/V(6.45b) * Re(10.12%) + D(1.71b)/V(6.45b) * Rd(6.58%) * (1-Tc(0.23)))
Discount Rate = 10.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.88%
[DCF Debug] Terminal Value 77.12% ; FCFF base≈805.8m ; Y1≈910.3m ; Y5≈1.23b
Fair Price DCF = 322.8 (EV 18.31b - Net Debt 1.55b = Equity 16.76b / Shares 51.9m; r=8.78% [WACC]; 5y FCF grow 15.10% → 2.90% )
EPS Correlation: -25.64 | EPS CAGR: -42.31% | SUE: -4.0 | # QB: 0
Revenue Correlation: 64.43 | Revenue CAGR: 15.17% | SUE: 1.95 | # QB: 1
EPS next Quarter (2026-03-31): EPS=2.50 | Chg30d=-0.012 | Revisions Net=-1 | Analysts=9
EPS next Year (2026-12-31): EPS=11.94 | Chg30d=+0.019 | Revisions Net=-1 | Growth EPS=-1.6% | Growth Revenue=-0.4%

Additional Sources for CROX Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle